Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant

類似資料

• Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant
  著者:: Dayal, Satish, 等
  出版事項: (2021)
• Effect of gastric acid‐reducing agents on the pharmacokinetics and efficacy of lemborexant
  著者:: Landry, Ishani, 等
  出版事項: (2020)
• Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant
  著者:: Landry, Ishani, 等
  出版事項: (2021)
• Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults
  著者:: Landry, Ishani, 等
  出版事項: (2020)
• Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder
  著者:: Lalovic, Bojan, 等
  出版事項: (2020)